Sarcoid uveitis: Diagnostic and therapeutic update;Uvéites sarcoïdosiques : actualités diagnostiques et thérapeutiques

Revue de Medecine Interne

Volumn 32, Issue 2, 2011, Pages 86-92

  Varron, L ^a   Abad, S ^b   Kodjikian, L ^a   Seve P ^a  

^a UNIVERSITÉ LYON 1   (France)

^b AVICENNE HOSPITAL   (France)

Author keywords

Anti TNF antibody; Corticosteroids; Methotrexate; Sarco dosis; Uveitis

Indexed keywords

CORTICOSTEROID; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

CLINICAL FEATURE; DRUG INDICATION; ENDOSCOPIC ECHOGRAPHY; EYE EXAMINATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LABORATORY TEST; NEEDLE BIOPSY; POSITRON EMISSION TOMOGRAPHY; RETINA MACULA CYSTOID EDEMA; SARCOID UVEITIS; SARCOIDOSIS; SHORT SURVEY; UVEITIS; VASCULITIS;

EID: 78751610195     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2010.09.003     Document Type: Short Survey

References (79)

1. Iannuzzi M.C., Rybicki B.A., Teirstein A.S. Sarcoidosis. N Engl J Med 2007, 357:2153-2165.
2. Bonfioli A.A., Orefice F. Sarcoidosis. Semin Ophthalmol 2005, 20:177-182.
3. Kitamei H., Kitaichi N., Namba K., Kotake S., Goda C., Kitamura M., et al. Clinical features of intraocular inflammation in Hokkaido, Japan. Acta Ophthalmol 2009, 87:424-428.
4. Bouillet L., Sarrot-Reynauld F., Gonzalvez B., Massot C., Romanet J., Mouillon M. Prise en charge diagnostique des uvéites: à propos d'une étude prospective de 125 patients. J Fr Ophtalmol 2000, 23:569-575.
5. Pivetti-Pezzi P., Accorinti M., La Cava M., Colabelli Gisoldi R.A., Abdulaziz M.A. Endogenous uveitis: an analysis of 1,417 cases. Ophthalmologica 1996, 210:234-238.
6. Jakob E., Reuland M.S., Mackensen F., Harsch N., Fleckenstein M., Lorenz H.M., et al. Uveitis subtypes in a german interdisciplinary uveitis center--analysis of 1916 patients. J Rheumatol 2009, 36:127-136.
7. Rodriguez A., Calonge M., Pedroza-Seres M., Akova Y.A., Messmer E.M., D'Amico D.J., et al. Referral patterns of uveitis in a tertiary eye care center. Arch Ophthalmol 1996, 114:593-599.
8. Mercanti A., Parolini B., Bonora A., Lequaglie Q., Tomazzoli L. Epidemiology of endogenous uveitis in north-eastern Italy. Analysis of 655 new cases. Acta Ophthalmol Scand 2001, 79:64-68.
9. Le Scanff J., Sève P., Kodjikian L., Grange J.D., Broussolle C. Apport de la consultation interniste dans le diagnostic étiologique des uvéites. Étude portant sur 66 patients. Rev Med Interne 2006, 27:671-678.
10. McCannel C.A., Holland G.N., Helm C.J., Cornell P.J., Winston J.V., Rimmer T.G. Causes of uveitis in the general practice of ophthalmology. UCLA Community-Based Uveitis Study Group. Am J Ophthalmol 1996, 121:35-46.
11. Samson C.M., Waheed N., Baltatzis S., Foster C.S. Methotrexate therapy for chronic noninfectious uveitis: analysis of a case series of 160 patients. Ophthalmology 2001, 108:1134-1139.
12. Oruc S., Kaplan A.D., Galen M., Kaplan H.J. Uveitis referral pattern in a Midwest University Eye Center. Ocul Immunol Inflamm 2003, 11:287-298.
13. Bodaghi B., Cassoux N., Wechsler B., Hannouche D., Fardeau C., Papo T., et al. Chronic severe uveitis: etiology and visual outcome in 927 patients from a single center. Medicine (Baltimore) 2001, 80:263-270.
14. Sève P., Billotey C., Janier M., Grange J.D., Broussolle C., Kodjikian L. Fluorodeoxyglucose positron emission tomography for the diagnosis of sarcoidosis in patients with unexplained chronic uveitis. Ocul Immunol Inflamm 2009, 17:179-184.
15. Chung Y.M., Lin Y.C., Liu Y.T., Chang S.C., Liu H.N., Hsu W.H. Uveitis with biopsy-proven sarcoidosis in Chinese - a study of 60 patients in a uveitis clinic over a period of 20 years. J Chin Med Assoc 2007, 70:492-496.
16. Abad S., Meyssonier V., Allali J., Gouya H., Giraudet A.L., Monnet D., et al. Association of peripheral multifocal choroiditis with sarcoidosis: a study of thirty-seven patients. Arthritis Rheum 2004, 51:974-982.
17. Khanna A., Sidhu U., Bajwa G., Malhotra V. Pattern of ocular manifestations in patients with sarcoidosis in developing countries. Acta Ophthalmol Scand 2007, 85:609-612.
18. Lee S.Y., Lee H.G., Kim D.S., Kim J.G., Chung H., Yoon Y.H. Ocular sarcoidosis in a Korean population. J Korean Med Sci 2009, 24:413-419.
19. Rothova A. Ocular involvement in sarcoidosis. Br J Ophthalmol 2000, 84:110-116.
20. Ganesh S.K., Agarwal M. Clinical and investigative profile of biopsy-proven sarcoid uveitis in India. Ocul Immunol Inflamm 2008, 16:17-22.
21. Evans M., Sharma O., LaBree L., Smith R.E., Rao N.A. Differences in clinical findings between Caucasians and African Americans with biopsy-proven sarcoidosis. Ophthalmology 2007, 114:325-333.
22. Baughman R.P., Teirstein A.S., Judson M.A., Rossman M.D., Yeager H., Bresnitz E.A., et al. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 2001, 164:1885-1889.
23. Spagnolo P., Sato H., Marshall S.E., Antoniou K.M., Ahmad T., Wells A.U., et al. Association between heat shock protein 70/Hom genetic polymorphisms and uveitis in patients with sarcoidosis. Invest Ophthalmol Vis Sci 2007, 48:3019-3025.
24. Jabs D.A., Nussenblatt R.B., Rosenbaum J.T. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 2005, 140:509-516.
25. Bodaghi B., Wechsler B., Du-Boutin L.T., Cassoux N., LeHoang P., Piette J.C. Uvéites chroniques sévères: classification, démarche diagnostique et principes thérapeutiques. Rev Med Interne 2003, 24:794-802.
26. Karma A., Huhti E., Poukkula A. Course and outcome of ocular sarcoidosis. Am J Ophthalmol 1988, 106:467-472.
27. Obenauf C.D., Shaw H.E., Sydnor C.F., Klintworth G.K. Sarcoidosis and its ophthalmic manifestations. Am J Ophthalmol 1978, 86:648-655.
28. Rothova A., Alberts C., Glasius E., Kijlstra A., Buitenhuis H.J., Breebaart A.C. Risk factors for ocular sarcoidosis. Doc Ophthalmol 1989, 72:287-296.
29. Jabs D.A., Johns C.J. Ocular involvement in chronic sarcoidosis. Am J Ophthalmol 1986, 102:297-301.
30. Akova Y.A., Foster C.S. Cataract surgery in patients with sarcoidosis-associated uveitis. Ophthalmology 1994, 101:473-479.
31. Crick R.P., Hoyle C., Smellie H. The eyes in sarcoidosis. Br J Ophthalmol 1961, 45:461-481.
32. Dana M.R., Merayo-Lloves J., Schaumberg D.A., Foster C.S. Prognosticators for visual outcome in sarcoid uveitis. Ophthalmology 1996, 103:1846-1853.
33. Uyama M. Uveitis in sarcoidosis. Int Ophthalmol Clin 2002, 42:143-150.
34. Bonfioli A.A., Damico F.M., Curi A.L., Orefice F. Intermediate uveitis. Semin Ophthalmol 2005, 20:147-154.
35. Smith J.A., Foster C.S. Sarcoidosis and its ocular manifestations. Int Ophthalmol Clin 1996, 36:109-125.
36. Lardenoye C.W., Van der Lelij A., de Loos W.S., Treffers W.F., Rothova A. Peripheral multifocal chorioretinitis: a distinct clinical entity?. Ophthalmology 1997, 104:1820-1826.
37. Stavrou A., Foster S. Sarcoidosis. Diagnosis and treatment of uveitis 2002, 710-725. W.B. Saunders Company, Philadelphia. S. Foster, A. Vitale (Eds.).
38. Crick R.P. Ocular sarcoidosis. Trans Opthal Soc U K 1955, 75:189-206.
39. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 1999;160:736-55.
40. Kaiser P.K., Lowder C.Y., Sullivan P., Sanislo S.R., Kosmorsky G.S., Meziane M.A., et al. Chest computerized tomography in the evaluation of uveitis in elderly women. Am J Ophthalmol 2002, 133:499-505.
41. Clement D., Postma G., Rothova A., Grutters J., Prokop M., de Jong P. Intraocular sarcoidosis: association of clinical characteristics of uveitis with positive chest high-resolution computed tomography findings. Br J Ophthalmol 2010, 94:219-222.
42. Takahashi T., Azuma A., Abe S., Kawanami O., Ohara K., Kudoh S. Significance of lymphocytosis in bronchoalveolar lavage in suspected ocular sarcoidosis. Eur Respir J 2001, 18:515-521.
43. de Boer S., Milne D.G., Zeng I., Wilsher M.L. Does CT scanning predict the likelihood of a positive transbronchial biopsy in sarcoidosis?. Thorax 2009, 64:436-439.
44. Herbort C.P., Rao N.A., Mochizuki M. International criteria for the diagnosis of ocular sarcoidosis: results of the first International Workshop On Ocular Sarcoidosis (IWOS). Ocul Immunol Inflamm 2009, 17:160-169.
45. Kawaguchi T., Hanada A., Horie S., Sugamoto Y., Sugita S., Mochizuki M. Evaluation of characteristic ocular signs and systemic investigations in ocular sarcoidosis patients. Jpn J Ophthalmol 2007, 51:121-126.
46. Nishiyama Y., Yamamoto Y., Fukunaga K., Takinami H., Iwado Y., Satoh K., et al. Comparative evaluation of 18F-FDG PET and 67Ga scintigraphy in patients with sarcoidosis. J Nucl Med 2006, 47:1571-1576.
47. Dufour D., Mereau P. Le syndrome de Possner-Schlossmann syndrome et la maladie de Besnier-Boeck-Schaumann. Bull Soc Ophtalmol Fr 1973, 73:1237-1239.
48. Chung Y.M., Lin Y.C., Huang D.F., Hwang D.K., Ho D.M. Conjunctival biopsy in sarcoidosis. J Chin Med Assoc 2006, 69:472-477.
49. Le Scanff J., Kodjikian L., Broussolle C., Sève P. Uvéites. Diagnostics difficiles en médecine interne 2008, 911-930. Maloine ed., Paris. H. Rousset, D. Vital-Durand, J. Dupond, M. Pavic (Eds.).
50. Tremblay A., Stather D.R., Maceachern P., Khalil M., Field S.K. A randomized controlled trial of standard vs endobronchial ultrasonography-guided transbronchial needle aspiration in patients with suspected sarcoidosis. Chest 2009, 136:340-346.
51. Nakajima T., Yasufuku K., Kurosu K., Takiguchi Y., Fujiwara T., Chiyo M., et al. The role of EBUS-TBNA for the diagnosis of sarcoidosis - comparisons with other bronchoscopic diagnostic modalities. Respir Med 2009, 103:1796-1800.
52. Tournoy K.G., Bolly A., Aerts J.G., Pierard P., De Pauw R., Leduc D., et al. The value of endoscopic ultrasound after bronchoscopy to diagnose thoracic sarcoidosis. Eur Respir J 2010, 35:1329-1335.
53. Rothova A., Suttorp-van Schulten M.S., Frits Treffers W., Kijlstra A. Causes and frequency of blindness in patients with intraocular inflammatory disease. Br J Ophthalmol 1996, 80:332-336.
54. Edelsten C., Pearson A., Joynes E., Stanford M.R., Graham E.M. The ocular and systemic prognosis of patients presenting with sarcoid uveitis. Eye (Lond) 1999, 13:748-753.
55. Hayashi K., Hayashi H. Intravitreal versus retrobulbar injections of triamcinolone for macular edema associated with branch retinal vein occlusion. Am J Ophthalmol 2005, 139:972-982.
56. Abad S., Sève P., Dhote R., Brézin A.P. Uvéites et médecine interne: stratégies diagnostiques et thérapeutiques. Rev Med Interne 2009, 30:492-500.
57. Jones N.P. Sarcoidosis and uveitis. Ophthalmol Clin North Am 2002, 15:319-326. (vi).
58. Dev S., McCallum R.M., Jaffe G.J. Methotrexate treatment for sarcoid-associated panuveitis. Ophthalmology 1999, 106:111-118.
59. Baughman R.P., Lower E.E. Leflunomide for chronic sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2004, 21:43-48.
60. Bhat P., Cervantes-Castaneda R.A., Doctor P.P., Anzaar F., Foster C.S. Mycophenolate mofetil therapy for sarcoidosis-associated uveitis. Ocul Immunol Inflamm 2009, 17:185-190.
61. Galor A., Jabs D.A., Leder H.A., Kedhar S.R., Dunn J.P., Peters G.B., et al. Comparison of antimetabolite drugs as corticosteroid-sparing therapy for noninfectious ocular inflammation. Ophthalmology 2008, 115:1826-1832.
62. Baughman R.P., Winget D.B., Lower E.E. Methotrexate is steroid sparing in acute sarcoidosis: results of a double blind, randomized trial. Sarcoidosis Vasc Diffuse Lung Dis 2000, 17:60-66.
63. Toussirot E, Pertuiset E. Agents anti-TNFa et sarcoïdose. Rev Med Interne. 10.1016/j.revmed.2010.02.007.
64. Baughman R.P., Lower E.E., Bradley D.A., Raymond L.A., Kaufman A. Etanercept for refractory ocular sarcoidosis: results of a double-blind randomized trial. Chest 2005, 128:1047-1062.
65. Judson M.A., Baughman R.P., Costabel U., Flavin S., Lo K.H., Kavuru M.S., et al. Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial. Eur Respir J 2008, 31:1189-1196.
66. Benitez-del-Castillo J.M., Martinez-de-la-Casa J.M., Pato-Cour E., Mendez-Fernandez R., Lopez-Abad C., Matilla M., et al. Long-term treatment of refractory posterior uveitis with anti-TNFalpha (infliximab). Eye (Lond) 2005, 19:841-845.
67. Cruz B.A., Reis D.D., Araujo C.A. Refractory retinal vasculitis due to sarcoidosis successfully treated with infliximab. Rheumatol Int 2007, 27:1181-1183.
68. Doty J.D., Mazur J.E., Judson M.A. Treatment of sarcoidosis with infliximab. Chest 2005, 127:1064-1071.
69. Kahn P., Weiss M., Imundo L.F., Levy D.M. Favorable response to high-dose infliximab for refractory childhood uveitis. Ophthalmology 2006, 113:860e2-864e2.
70. Pritchard C., Nadarajah K. Tumour necrosis factor alpha inhibitor treatment for sarcoidosis refractory to conventional treatments: a report of five patients. Ann Rheum Dis 2004, 63:318-320.
71. Saleh S., Ghodsian S., Yakimova V., Henderson J., Sharma O.P. Effectiveness of infliximab in treating selected patients with sarcoidosis. Respir Med 2006, 100:2053-2059.
72. Saurenmann R.K., Levin A.V., Rose J.B., Parker S., Rabinovitch T., Tyrrell P.N., et al. Tumour necrosis factor alpha inhibitors in the treatment of childhood uveitis. Rheumatology (Oxford) 2006, 45:982-989.
73. Roberts S.D., Wilkes D.S., Burgett R.A., Knox K.S. Refractory sarcoidosis responding to infliximab. Chest 2003, 124:2028-2031.
74. Baughman R.P., Bradley D.A., Lower E.E. Infliximab in chronic ocular inflammation. Int J Clin Pharmacol Ther 2005, 43:7-11.
75. Panselinas E., Rodgers J.K., Judson M.A. Clinical outcomes in sarcoidosis after cessation of infliximab treatment. Respirology 2009, 14:522-528.
76. Hashkes P.J., Shajrawi I. Sarcoid-related uveitis occurring during etanercept therapy. Clin Exp Rheumatol 2003, 21:645-646.
77. Sturfelt G., Christensson B., Bynke G., Saxne T. Neurosarcoidosis in a patient with rheumatoid arthritis during treatment with infliximab. J Rheumatol 2007, 34:2313-2314.
78. Daien C.I., Monnier A., Claudepierre P., Constantin A., Eschard J.P., Houvenagel E., et al. Sarcoid-like granulomatosis in patients treated with tumor necrosis factor blockers: 10 cases. Rheumatology (Oxford) 2009, 48:883-886.
79. Louie G.H., Chitkara P., Ward M.M. Relapse of sarcoidosis upon treatment with etanercept. Ann Rheum Dis 2008, 67:896-898.